Rankings
▼
Calendar
SANA Q4 2019 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
SANA
Sana Biotechnology, Inc.
$845M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$45M
Net Income
-$43M
EPS (Diluted)
$-0.27
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$40M
Stock-Based Comp.
$487,000
Balance Sheet
Total Assets
$415M
Total Liabilities
$558M
Stockholders' Equity
-$143M
Cash & Equivalents
$80M
← FY 2019
All Quarters
Q1 2020 →